Cargando…
Monkeypox in Patient Immunized with ACAM2000 Smallpox Vaccine During 2022 Outbreak
We report a case of monkeypox in the United States in a patient who had been vaccinated with ACAM2000 smallpox vaccine 8 years earlier. Despite his vaccination status, he still contracted disease. He showed prodromal symptoms preceding development of painless penile lesions that later coalesced.
Autores principales: | Turner, Matthew, Mandia, Jeremy, Keltner, Case, Haynes, Robert, Faestel, Paul, Mease, Luke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622228/ https://www.ncbi.nlm.nih.gov/pubmed/36104166 http://dx.doi.org/10.3201/eid2811.221215 |
Ejemplares similares
-
ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile
por: Nalca, Aysegul, et al.
Publicado: (2010) -
SG-APSIC1035: Prospective safety surveillance study of ACAM2000 smallpox vaccine in deployed military personnel
por: Yeo, Kevin, et al.
Publicado: (2023) -
Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention
por: Kandeel, Mahmoud, et al.
Publicado: (2023) -
Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge()()
por: Russo, Andrew T., et al.
Publicado: (2020) -
Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications and Adverse Effects of JYNNEOS and ACAM2000 Monkeypox Vaccines
por: Meo, Sultan Ayoub, et al.
Publicado: (2022)